Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
EMD 521873 in Advanced Solid Tumors, MTD Finding
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae
- Status
- COMPLETED
- Phase
- PHASE2
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Relapsed and/or Refractory Non-Hodgkin Lymphoma Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1
Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1